Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Anticancer Research|April 27, 2024
CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in <i>KRAS</i> Mutant Cholangiocarcinoma Cell LinesDA Sol Lee, Min Woo Han, Yonghyun Kang, et al.
The American Journal of Gastroenterology|August 17, 2004
Autoimmune chronic pancreatitisKyu-Pyo Kim, Myung-Hwan Kim, Moon Hee Song, et al.
Clinical Therapeutics|November 25, 2010
Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteersTae-Eun Kim, Kyu-Pyo Kim, Bo-Hyung Kim, et al.
Therapeutic Advances in Medical Oncology|April 2, 2021
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapyKyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, et al.
World Journal of Gastroenterology|May 12, 2006
Diagnostic criteria for autoimmune chronic pancreatitis revisitedKyu-Pyo Kim, Myung-Hwan Kim, Jong Cheol Kim, et al.
British Journal of Cancer|January 13, 2017
Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patientsBum Jun Kim, Changhoon Yoo, Kyu-Pyo Kim, et al.
Anticancer Research|February 27, 2026
Erlotinib Induces Cell Death by Blocking NIX-mediated Mitophagy Through Lysosomal Swelling in IDH1-mutant CholangiocarcinomaYonghyun Kang, Chorong Kim, Chan Yeop Jeong, et al.
Colloids and Surfaces. B, Biointerfaces|February 13, 2018
Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapyShaohui Zheng, Jiwon Han, Zhen Jin, et al.
BMC Cancer|November 10, 2018
Disease severity-based evaluation of utility weights for lung cancer-related health states in KoreaEun-Jung Kim, Minsu Ock, Kyu-Pyo Kim, et al.
Medical Oncology (Northwood, London, England)|April 7, 2018
Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatmentJae-Joon Kim, Jihoon Kang, Yong Sang Hong, et al.
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Anticancer Research|April 27, 2024
CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in <i>KRAS</i> Mutant Cholangiocarcinoma Cell LinesDA Sol Lee, Min Woo Han, Yonghyun Kang, et al.
The American Journal of Gastroenterology|August 17, 2004
Autoimmune chronic pancreatitisKyu-Pyo Kim, Myung-Hwan Kim, Moon Hee Song, et al.
Clinical Therapeutics|November 25, 2010
Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteersTae-Eun Kim, Kyu-Pyo Kim, Bo-Hyung Kim, et al.
Therapeutic Advances in Medical Oncology|April 2, 2021
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapyKyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, et al.
World Journal of Gastroenterology|May 12, 2006
Diagnostic criteria for autoimmune chronic pancreatitis revisitedKyu-Pyo Kim, Myung-Hwan Kim, Jong Cheol Kim, et al.
British Journal of Cancer|January 13, 2017
Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patientsBum Jun Kim, Changhoon Yoo, Kyu-Pyo Kim, et al.
Anticancer Research|February 27, 2026
Erlotinib Induces Cell Death by Blocking NIX-mediated Mitophagy Through Lysosomal Swelling in IDH1-mutant CholangiocarcinomaYonghyun Kang, Chorong Kim, Chan Yeop Jeong, et al.
Colloids and Surfaces. B, Biointerfaces|February 13, 2018
Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapyShaohui Zheng, Jiwon Han, Zhen Jin, et al.
BMC Cancer|November 10, 2018
Disease severity-based evaluation of utility weights for lung cancer-related health states in KoreaEun-Jung Kim, Minsu Ock, Kyu-Pyo Kim, et al.
Medical Oncology (Northwood, London, England)|April 7, 2018
Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatmentJae-Joon Kim, Jihoon Kang, Yong Sang Hong, et al.
Pageof 22